日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Prognostic Biomarker of Fertility-Preserving Hormonal Therapy Based on Multigene Panel Testing for Endometrial Cancer

基于子宫内膜癌多基因检测的生育力保留激素治疗预后生物标志物

期刊:Cancer Science
影响因子:4.3
doi:10.1111/cas.70240
Hirano, Takuro; Sakai, Kensuke; Yoshimura, Takuma; Chiyoda, Tatsuyuki; Nakamura, Kohei; Aimono, Eriko; Kawaida, Miho; Nishihara, Hiroshi; Susumu, Nobuyuki; Aoki, Daisuke; Yamagami, Wataru
肿瘤
子宫内膜癌
肿瘤免疫
免疫/内分泌
发表日期：2026
文献求助 收藏

Prognostic impact of peritoneal cytology on treating endometrial cancer using data from the Japan Society of Obstetrics and Gynecology cancer registry

利用日本妇产科学会癌症登记处的数据，探讨腹膜细胞学检查对子宫内膜癌治疗预后的影响

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e41
Sakai, Kensuke; Yamagami, Wataru; Takahashi, Fumiaki; Tokunaga, Hideki; Yamamoto, Eiko; Yokoyama, Yoshihito; Yoshino, Kiyoshi; Kawana, Kei; Nagase, Satoru
细胞生物学
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

Characteristics of endometrial cancer progressed to extrauterine lesions following fertility preserving medroxyprogesterone acetate therapy for young endometrial cancer patients

年轻子宫内膜癌患者接受保留生育功能的醋酸甲羟孕酮治疗后，子宫内膜癌进展为子宫外病变的特征

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2025.36.e104
Kitazawa, Shoko; Sakai, Kensuke; Kawaida, Miho; Chiyoda, Tatsuyuki; Nishio, Hiroshi; Banno, Kouji; Susumu, Nobuyuki; Yamagami, Wataru
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

High-Throughput Drug Screening of Clear Cell Ovarian Cancer Organoids Reveals Vulnerability to Proteasome Inhibitors and Dinaciclib and Identifies AGR2 as a Therapeutic Target.

对透明细胞卵巢癌类器官进行高通量药物筛选，揭示其对蛋白酶体抑制剂和Dinaciclib的敏感性，并确定AGR2为治疗靶点

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0024
Yoshimura Takuma, Kamatani Takashi, Ookubo Aki, Takahashi Mio, Itoh Manabu, Ebisudani Toshiki, Masugi Yohei, Toyonaga Tomomi, Hamamoto Junko, Saotome Keiko, Sakai Kensuke, Yoshihama Tomoko, Moritoki Nobuko, Shibata Shinsuke, Yasuda Hiroyuki, Sato Toshiro, Sato Taka-Aki, Aoki Daisuke, Yamagami Wataru, Tsunoda Tatsuhiko, Chiyoda Tatsuyuki
细胞生物学
卵巢癌
3D/类器官
发表日期：2025
文献求助 收藏

Safety management in Cushing syndrome during osilodrostat treatment based on morning blood cortisol level

基于晨起血皮质醇水平的奥西洛司他治疗库欣综合征的安全性管理

期刊:Endocrine Journal
影响因子:2.1
doi:10.1507/endocrj.EJ24-0696
Katabami, Takuyuki; Matsuba, Ren; Nagasaka, Tomoyuki; Yamamoto, Yutaro; Sakai, Kensuke; Sone, Masakatsu
库欣综合征
免疫/内分泌
发表日期：2025
文献求助 收藏

Safe Implementation of Robotic Surgery for Gynecologic Diseases at a Tertiary Center: Retrospective Analysis of 149 Cases and Review of the Literature

在三级医疗中心安全实施妇科疾病机器人手术：149例病例回顾性分析及文献综述

期刊:Gynecology and Minimally Invasive Therapy-GMIT
影响因子:1.7
doi:10.4103/gmit.gmit_144_23
Yoshimura, Takuma; Nishio, Hiroshi; Sakai, Kensuke; Nogami, Yuya; Hayashi, Shigenori; Yamagami, Wataru
发表日期：2025
文献求助 收藏

Splenic Metastasis of Endometrial Carcinoma Manifesting as a Hemorrhagic Splenic Cyst 17 Years After Surgery

子宫内膜癌脾转移，术后17年表现为出血性脾囊肿

期刊:Asian Journal of Endoscopic Surgery
影响因子:0.9
doi:10.1111/ases.70118
Kitago, Minoru; Kamiyama, Masato; Abe, Yuta; Hasegawa, Yasushi; Hori, Shutaro; Tanaka, Masayuki; Nakano, Yutaka; Masugi, Yohei; Ueno, Akihisa; Sakai, Kensuke; Yokota, Megumi; Yamagami, Wataru; Kitagawa, Yuko
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

A case of primary ovarian clear cell carcinoma with ETV6::NTRK3 fusion.

一例伴有ETV6::NTRK3融合的原发性卵巢透明细胞癌。

期刊:International Cancer Conference Journal
影响因子:0.5
doi:10.1007/s13691-025-00795-6
Ochiai Daisuke, Chiyoda Tatsuyuki, Nakamura Kohei, Takamatsu Reika, Jisaka Mitsuyo, Sakamaki Tomomi, Takahashi Mio, Kimura Yumiko, Oki Shinya, Yoshihama Tomoko, Sakai Kensuke, Nishihara Hiroshi, Yamagami Wataru
细胞生物学
Trk
NTRK3
发表日期：2025
文献求助 收藏

Next-generation sequencing outperforms Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) in endometrial cancer molecular classification

在子宫内膜癌分子分型方面，新一代测序优于子宫内膜癌主动分子风险分类器（ProMisE）。

期刊:
影响因子:
doi:10.1038/s44276-025-00145-2
Yoshimura, Takuma; Nakamura, Kohei; Chiyoda, Tatsuyuki; Takamatsu, Reika; Kawano, Ryutaro; Aimono, Eriko; Kawaida, Miho; Sakai, Kensuke; Masugi, Yohei; Nishihara, Hiroshi; Yamagami, Wataru
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2025
文献求助 收藏

A phase II trial evaluating the efficacy and safety of repeated high dose medroxyprogesterone acetate (MPA) therapy for patients with recurrent early-stage endometrial cancer or atypical endometrial hyperplasia: Japanese Gynecologic Oncology Group study (JGOG2051/KGOG2031, REMPA trial)

一项 II 期试验评估重复高剂量醋酸甲羟孕酮 (MPA) 治疗复发性早期子宫内膜癌或非典型子宫内膜增生患者的疗效和安全性：日本妇科肿瘤协作组研究 (JGOG2051/KGOG2031，REMPA 试验)

期刊:Journal of Gynecologic Oncology
影响因子:3.7
doi:10.3802/jgo.2024.35.e106
Sakai, Kensuke; Yamagami, Wataru; Sato, Yasunori; Susumu, Nobuyuki; Yokoyama, Yoshihito; Takehara, Kazuhiro; Mandai, Masaki; Okamoto, Aikou
肿瘤
子宫内膜癌
肿瘤免疫
发表日期：2024
文献求助 收藏